Wellington Management Group LLP Regeneron Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 440,609 shares of REGN stock, worth $310 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

440,609

Previous 1,061,791 58.5%

Holding current value

$310 Million

Previous $1.12 Billion 58.5%

% of portfolio

0.08%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $636 Million - $747 Million	-621,182 Reduced 58.5%	440,609 $463 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $27.5 Million - $33.4 Million	-31,184 Reduced 2.85%	1,061,791 $1.12 Billion
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $987 Million - $1.09 Billion	1,092,975 New	1,092,975 $1.05 Billion
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $854 Million - $972 Million	1,102,090 New	1,102,090 $968 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $112 Million - $137 Million	-162,047 Reduced 9.71%	1,506,885 $1.24 Billion
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $69.3 Million - $82.2 Million	-98,987 Reduced 5.6%	1,668,932 $1.2 Billion
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $441 Million - $536 Million	-648,328 Reduced 26.83%	1,767,919 $1.45 Billion
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $19.1 Million - $20.7 Million	-27,042 Reduced 1.11%	2,416,247 $1.74 Billion
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $34.6 Million - $43.7 Million	60,342 Added 2.53%	2,443,289 $1.68 Billion
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $278 Million - $375 Million	-507,256 Reduced 17.55%	2,382,947 $1.41 Billion
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $146 Million - $171 Million	-244,572 Reduced 7.8%	2,890,203 $2.02 Billion
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $127 Million - $157 Million	-233,290 Reduced 6.93%	3,134,775 $1.98 Billion
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $396 Million - $469 Million	-689,317 Reduced 16.99%	3,368,065 $2.04 Billion
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $85.6 Million - $101 Million	181,002 Added 4.67%	4,057,382 $2.27 Billion
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $110 Million - $135 Million	245,858 Added 6.77%	3,876,380 $1.83 Billion
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $72.7 Million - $92.4 Million	151,995 Added 4.37%	3,630,522 $1.75 Billion
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $101 Million - $122 Million	-185,341 Reduced 5.06%	3,478,527 $1.95 Billion
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $793 Million - $1.03 Billion	1,607,109 Added 78.14%	3,663,868 $2.28 Billion
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $64.9 Million - $95.5 Million	-193,156 Reduced 8.59%	2,056,759 $1 Billion
Q4 2019 Feb 11, 2020	BUY	$274.13 - $376.51 $617 Million - $847 Million	2,249,915 New	2,249,915 $845 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Regeneron Pharmaceuticals, Inc. Transaction History